Uncertain Times: Korean Pharma Braces For Trump, Political Turmoil
Mixed Signals For Industry
At a new year’s briefing, KPBMA's president talked about what may be ahead for Korean biopharma firms in a challenging and uncertain environment amid the start of the second Trump Administration and ongoing political turmoil in Korea.
